Clinical trial
Nobori Dual Antiplatelet Therapy as Appropriate Duration.
NCT01514227 is registered in ClinicalTrials.gov with Associations for Establishment of Evidence in Interventions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nobori Dual Antiplatelet Therapy as Appropriate Duration.
- Lead sponsor
- Associations for Establishment of Evidence in Interventions
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2011
- Completion date
- June 30, 2016
- Enrollment
- 3,773 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.